A detailed history of Charles Schwab Investment Management Inc transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 259,812 shares of PROK stock, worth $639,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
259,812
Previous 255,103 1.85%
Holding current value
$639,137
Previous $454,000 6.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$1.2 - $1.76 $5,650 - $8,287
4,709 Added 1.85%
259,812 $426,000
Q4 2023

Feb 06, 2024

SELL
$1.21 - $4.76 $16,506 - $64,935
-13,642 Reduced 5.08%
255,103 $454,000
Q3 2023

Nov 08, 2023

BUY
$4.32 - $13.08 $526,880 - $1.6 Million
121,963 Added 83.09%
268,745 $1.23 Million
Q2 2023

Aug 09, 2023

BUY
$9.0 - $13.0 $1.32 Million - $1.91 Million
146,782 New
146,782 $1.64 Million

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $151M
More about PROK
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.